查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933340

全球心臟PET（正子断层扫描）市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测（2026-2034）

Cardiology Positron Emission Tomography Scan Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 请询问到货日

价格

心臟PET（正子断层扫描）市场成长因素

预计全球心臟PET（正子断层扫描）市场规模在2025年将达到19.3亿美元，2026年将成长至19.8亿美元，到2034年将达到28.3亿美元，预测期内复合年增长率（CAGR）为4.55%。心臟PET是一种非侵入性影像技术，它使用放射性示踪剂来评估心臟代谢、心肌灌注、发炎和活力。这些检查对于诊断冠状动脉疾病 (CAD)、评估心肌梗塞后的心臟损伤以及製定诸如搭桥手术等外科手术方案至关重要。

到 2025 年，北美将以 10.73% 的市场占有率引领市场，这主要得益于心臟病患病率的上升、先进的医疗基础设施以及诊断成像系统技术的持续创新。主要参与者包括 Sonic Healthcare Limited、Apex Radiology、Alliance Medical 和 Siemens Healthineers Limited，它们均透过有机成长和无机成长相结合的方式在全球扩张。

市场动态

驱动因素：PET 扫描仪和放射性药物的技术进步是主要驱动因素。西门子医疗等公司推出了 Biograph Trinion PET/CT 扫描仪等先进系统，这些系统提供人工智慧驱动的工作流程和整合式患者监护功能，以提高诊断准确性和患者舒适度。心血管疾病盛行率不断上升、人口老化以及对非侵入性诊断方法的偏好进一步推动了市场成长。

限制因素：PET/CT 系统的高昂成本（22.5 万美元至 75 万美元）以及熟练的核子医学专业人员短缺是重要的障碍。贸易保护主义，包括新兴市场的关税和监管要求，可能会进一步延缓技术的普及并增加成本。

机会：对能够加快工作流程的先进诊断影像系统的需求不断增长，带来了巨大的机会。 IONETIX 和 Provision Diagnostic Imaging 等全球和本地公司之间的合作旨在开发能够更快获得检测结果的先进诊断成像流程。

挑战：短寿命放射性示踪剂的供应有限，尤其是那些需要现场迴旋加速器的示踪剂，限制了市场成长。供应链中断、监管检查和维护停机可能会延迟诊断程序并降低系统可用性。

市场趋势

市场正向混合影像系统（例如 PET/CT 和 PET/MRI）转型，这些系统可提供更优异的功能和解剖解析度。这些系统能够改善心肌灌注和冠状动脉血流储备的评估。此外，人工智慧和软体的整合正在提高心臟成像的诊断准确性和操作效率。

细分市场分析

依资金来源划分：由于能够获得更多个人化医疗服务和多样化的服务提供者，私人医疗保险/自费市场占主导地位。由于报销政策不足，公共保险市场的成长预计将会放缓，但诸如 2025 年 CMS 提案等政策改革正在扩大 PET/CT 检查的覆盖范围。

依服务提供者划分：医院凭藉其先进的设施、训练有素的人员以及处理复杂心臟手术的能力，占了最大的市场占有率。由于等待时间缩短、成本效益提高以及与影像技术供应商合作增多，诊断中心预计将以最高的复合年增长率增长。其他服务提供者，例如研究机构和心臟中心，由于患者偏好有限，增长较为缓慢。

区域展望

  • 北美：预计到2026年，该市场规模将达到11.3亿美元，主要受冠状动脉疾病高发生率和对先进诊断工具投资的推动。美国和加拿大凭藉其强大的医疗保健基础设施和精准诊断技术的应用，处于领先地位。
  • 欧洲：该地区继续保持显着的市场占有率，主要得益于技术应用和旨在提高诊断效率的合作举措。英国为诊断数位化投入3.34亿美元等投资，正在推动该地区的成长。
  • 亚太地区：预计该地区将实现最高的复合年增长率，主要受意识提高、政府投资以及中国和日本等国在放射性药物生产方面开展的合作的推动。 拉丁美洲：成长主要受心血管疾病盛行率上升和对先进诊断技术投资的推动。 中东和非洲：由于医疗保健支出增加、可支配收入成长以及政府主导的先进心臟影像诊断技术发展计划，预计将保持稳定成长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要产业趋势：併购、业务合作等
  • 主要国家心臟病盛行率（2025 年）
  • 新产品发布
  • 主要参与者的关键产业趋势

第五章 全球心臟 PET（正子断层扫描）市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依资金来源划分
    • 公共医疗保险
    • 私人医疗保险/自费
  • 市场分析、洞察与预测：依服务提供者划分
    • 医院
    • 诊断中心
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美心臟PET（正子断层扫描）市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 美国
    • 加拿大

第七章：欧洲心臟PET（正子断层扫描）市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章：亚太地区心臟PET（正子断层扫描）市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚亚洲
    • 亚太其他地区

第九章：拉丁美洲心臟PET（正子断层扫描）市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲心臟PET（正子断层扫描）市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会（GCC）国家
    • 南非
    • 中东和非洲其他地区

第十一章 竞争格局分析

  • 全球市占率分析（2025）
  • 公司简介
    • RadNet, Inc.
    • Sonic Healthcare Limited
    • Akumin Inc.
    • Apex Radiology
    • Alliance Medical Limited
    • Novant Health
    • InHealth Group
    • Dignity Health
    • Concord Medical
    • Siemens Healthcare Limited
    • Mediworks
    • 其他主要参与者
Product Code: FBI113310

Growth Factors of cardiology positron emission tomography (PET) scan Market

The global cardiology positron emission tomography (PET) scan market was valued at USD 1.93 billion in 2025 and is projected to grow to USD 1.98 billion in 2026, reaching USD 2.83 billion by 2034, registering a CAGR of 4.55% during the forecast period. Cardiac PET is a non-invasive imaging procedure that uses radioactive tracers to evaluate heart metabolism, myocardial perfusion, inflammation, and viability. These scans are critical for diagnosing coronary artery disease (CAD), evaluating heart damage post-heart attack, and planning surgical procedures such as bypass surgeries.

North America dominated the market in 2025 with a 10.73% share, driven by the rising prevalence of cardiac conditions, advanced healthcare infrastructure, and continual technological advancements in imaging systems. Key players in the market include Sonic Healthcare Limited, Apex Radiology, Alliance Medical, and Siemens Healthcare Limited, which are adopting both organic and inorganic strategies to expand globally.

Market Dynamics

Drivers: Technological advancements in PET scanners and radiopharmaceuticals are primary drivers. Companies such as Siemens Healthineers have launched advanced systems like the Biograph Trinion PET/CT scanner, offering AI-powered workflow and integrated patient monitoring, improving diagnostic accuracy and patient comfort. The growing prevalence of cardiovascular diseases, aging population, and preference for non-invasive diagnostics further propel market growth.

Restraints: The high cost of PET/CT systems, ranging from USD 225,000 to USD 750,000, and the shortage of skilled nuclear medicine professionals are significant barriers. Trade protectionism, including tariffs and regulatory requirements in emerging markets, can further delay adoption and increase costs.

Opportunities: Rising demand for advanced imaging systems with faster workflows presents a substantial opportunity. Collaborations between global and local companies, such as IONETIX and Provision Diagnostic Imaging, aim to develop advanced imaging procedures with shorter turnaround times.

Challenges: Limited availability of radiotracers, especially those requiring on-site cyclotrons due to short half-lives, constrains market growth. Supply chain disruptions, regulatory inspections, and maintenance downtimes can delay diagnostic procedures and reduce system utilization.

Market Trends

The market is witnessing a shift toward hybrid imaging systems, such as PET/CT and PET/MRI, which provide superior functional and anatomical resolution. These systems improve assessment of myocardial perfusion and coronary flow reserve. Additionally, AI and software integrations are enhancing diagnostic precision and operational efficiency in cardiac imaging.

Segmentation Analysis

By Source of Payment: The private health insurance/out-of-pocket segment dominates due to better access to personalized treatment and a wider range of service providers. The public insurance segment is expected to grow slowly, limited by insufficient reimbursement policies, though policy reforms such as the 2025 CMS proposal aim to enhance coverage for PET/CT procedures.

By Service Provider: Hospitals retain the largest share due to advanced facilities, trained personnel, and capability to handle complex cardiac procedures. Diagnostic centers are projected to grow at the fastest CAGR because of shorter waiting times, cost-effectiveness, and increasing collaborations with imaging technology providers. Other service providers, such as research institutes and cardiac centers, exhibit stagnant growth due to limited patient preference.

Regional Outlook

  • North America: Market value stood at USD 1.13 billion in 2026, driven by high CAD prevalence and investments in advanced diagnostic tools. The U.S. and Canada are leading due to robust healthcare infrastructure and adoption of precision diagnostics.
  • Europe: Maintains a significant share due to technological adoption and collaborative initiatives for improving diagnostic efficiency. Investments, such as the UK's USD 334 million allocation for diagnostic digitalization, support growth.
  • Asia Pacific: Expected to register the highest CAGR, fueled by rising awareness, government investments, and partnerships for radiopharmaceutical production in countries like China and Japan.
  • Latin America: Growth driven by increasing cardiovascular disease prevalence and investments in advanced diagnostics.
  • Middle East & Africa: Steady growth due to rising healthcare spending, disposable incomes, and government initiatives for advanced cardiac imaging.

Competitive Landscape

The market is fragmented yet dominated by key players including Sonic Healthcare Limited, Apex Radiology, Siemens Healthcare Limited, and Novant Health, who focus on innovation, strategic partnerships, and distribution expansion. Notable developments include Positron Corporation's PET/CT rental program (2024) and Siemens Healthcare's high-performance PET/CT scanner launch (2024), enhancing operational efficiency and diagnostic precision.

Conclusion

The global cardiology PET scan market is poised for steady growth, from USD 1.93 billion in 2025 to USD 2.83 billion by 2034, driven by technological innovations, rising cardiac disease prevalence, and increasing demand for non-invasive, high-resolution imaging. North America maintains dominance, while Asia Pacific offers the highest growth potential due to increased awareness and investments. Despite challenges like high equipment costs, skilled workforce shortage, and radiotracer availability, the adoption of hybrid imaging systems, AI integration, and private insurance-driven healthcare solutions are expected to sustain market expansion. Leading players focusing on innovation and partnerships will shape the competitive landscape in the coming years.

Segmentation By Source of Payment

  • Public
  • Private Health Insurance/Out-of-pocket

By Service Provider

  • Hospitals
  • Diagnostic Centers
  • Others

By Geography

  • North America (By Source of Payment, Service Provider, and Country)
    • U.S.
    • Canada
  • Europe (By Source of Payment, Service Provider, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Source of Payment, Service Provider, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Source of Payment, Service Provider, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Source of Payment, Service Provider, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Recent Industry Developments such as Partnerships, Mergers, and Acquisitions
  • 4.2. Prevalence of Cardiac Conditions, Key Countries, 2025
  • 4.3. New Product Launches
  • 4.4. Key Industry Developments, Key Players

5. Global Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 5.1.1. Public
    • 5.1.2. Private Health Insurance/Out-of-pocket
  • 5.2. Market Analysis, Insights and Forecast - By Service Providers
    • 5.2.1. Hospitals
    • 5.2.2. Diagnostic Centers
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 6.1.1. Public
    • 6.1.2. Private Health Insurance/Out-of-pocket
  • 6.2. Market Analysis, Insights and Forecast - By Service Providers
    • 6.2.1. Hospitals
    • 6.2.2. Diagnostic Centers
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 7.1.1. Public
    • 7.1.2. Private Health Insurance/Out-of-pocket
  • 7.2. Market Analysis, Insights and Forecast - By Service Providers
    • 7.2.1. Hospitals
    • 7.2.2. Diagnostic Centers
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Spain
    • 7.3.5. Italy
    • 7.3.6. Scandinavia
    • 7.3.7. Rest of Europe

8. Asia pacific Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 8.1.1. Public
    • 8.1.2. Private Health Insurance/Out-of-pocket
  • 8.2. Market Analysis, Insights and Forecast - By Service Providers
    • 8.2.1. Hospitals
    • 8.2.2. Diagnostic Centers
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific

9. Latin America Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 9.1.1. Public
    • 9.1.2. Private Health Insurance/Out-of-pocket
  • 9.2. Market Analysis, Insights and Forecast - By Service Providers
    • 9.2.1. Hospitals
    • 9.2.2. Diagnostic Centers
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 10.1.1. Public
    • 10.1.2. Private Health Insurance/Out-of-pocket
  • 10.2. Market Analysis, Insights and Forecast - By Service Providers
    • 10.2.1. Hospitals
    • 10.2.2. Diagnostic Centers
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.3.1. GCC
    • 10.3.2. South Africa
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. RadNet, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Sonic Healthcare Limited
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Akumin Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Apex Radiology
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Alliance Medical Limited
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Novant Health
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. InHealth Group
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Dignity Health
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Concord Medical
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Siemens Healthcare Limited
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. Mediworks
      • 11.2.11.1. Overview
      • 11.2.11.2. Products
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)
    • 11.2.12. Other Prominent Players
      • 11.2.12.1. Overview
      • 11.2.12.2. Products
      • 11.2.12.3. SWOT Analysis
      • 11.2.12.4. Recent Developments
      • 11.2.12.5. Strategies
      • 11.2.12.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
  • Table 2: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
  • Table 3: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 4: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
  • Table 5: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
  • Table 6: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 7: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
  • Table 8: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
  • Table 9: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
  • Table 11: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
  • Table 12: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
  • Table 14: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
  • Table 15: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
  • Table 17: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
  • Table 18: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Cardiology Positron Emission Tomography Scan Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025 & 2034
  • Figure 3: Global Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025 & 2034
  • Figure 4: Global Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Region, 2025 & 2034
  • Figure 5: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
  • Figure 6: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
  • Figure 7: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
  • Figure 8: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
  • Figure 9: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country, 2025 & 2034
  • Figure 10: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country, 2025
  • Figure 11: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
  • Figure 12: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
  • Figure 13: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
  • Figure 14: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
  • Figure 15: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
  • Figure 18: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
  • Figure 19: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
  • Figure 20: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
  • Figure 21: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
  • Figure 24: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
  • Figure 25: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
  • Figure 26: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
  • Figure 27: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 29: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
  • Figure 30: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
  • Figure 31: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
  • Figure 32: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
  • Figure 33: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 35: Global Cardiology Positron Emission Tomography Scan Market Share (%), By Company, 2025